Portfolio Holdings Detail for ISIN IE00BGPP8L80
Stock Name / Fund iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF Ticker WMVG(GBP) LSE
ETF Ticker WMVG.L(GBP) LSE

Holdings detail for INCY

Stock Name	Incyte Corporation
Ticker	INCY(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US45337C1027
LEI	549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib: (RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update: Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY): Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00: Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts: Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price: In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY): Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC: Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY): Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.: Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock: Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.: Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY): Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC: Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY): Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY): State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY): Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY): Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY): Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus: Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc) INCY holdings

Date	Number of INCY Shares Held	Base Market Value of INCY Shares	Local Market Value of INCY Shares	Change in INCY Shares Held	Change in INCY Base Value	Current Price per INCY Share Held	Previous Price per INCY Share Held
2025-11-12 (Wednesday)	111,401	USD 12,060,272	USD 12,060,272
2025-11-11 (Tuesday)	111,401	USD 12,049,132	USD 12,049,132	0	USD 242,854	USD 108.16	USD 105.98
2025-11-10 (Monday)	111,401	USD 11,806,278	USD 11,806,278	0	USD 0	USD 105.98	USD 105.98
2025-11-07 (Friday)	111,401	USD 11,806,278	USD 11,806,278	0	USD 86,893	USD 105.98	USD 105.2
2025-11-06 (Thursday)	111,401	USD 11,719,385	USD 11,719,385	0	USD -55,701	USD 105.2	USD 105.7
2025-11-05 (Wednesday)	111,401	USD 11,775,086	USD 11,775,086	0	USD 309,695	USD 105.7	USD 102.92
2025-11-04 (Tuesday)	111,401	USD 11,465,391	USD 11,465,391	-1,064	USD 42,321	USD 102.92	USD 101.57
2025-11-03 (Monday)	112,465	USD 11,423,070	USD 11,423,070	0	USD 909,842	USD 101.57	USD 93.48
2025-10-31 (Friday)	112,465	USD 10,513,228	USD 10,513,228	504	USD 146,759	USD 93.48	USD 92.59
2025-10-30 (Thursday)	111,961	USD 10,366,469	USD 10,366,469	0	USD 269,826	USD 92.59	USD 90.18
2025-10-29 (Wednesday)	111,961	USD 10,096,643	USD 10,096,643	0	USD -164,583	USD 90.18	USD 91.65
2025-10-28 (Tuesday)	111,961	USD 10,261,226	USD 10,261,226	-1,008	USD -253,929	USD 91.65	USD 93.08
2025-10-27 (Monday)	112,969	USD 10,515,155	USD 10,515,155	0	USD 203,345	USD 93.08	USD 91.28

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00BGPP8L80

Show aggregate share trades of INCY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-04 SELL -1,064 103.860 100.020 100.404 USD -106,830 71.62 Loss of -30,629 on sale
2025-10-31 BUY 504 95.100 92.058 92.362 USD 46,550 71.37
2025-10-28 SELL -1,008 91.650 93.980 93.747 USD -94,497 71.08 Loss of -22,844 on sale
2025-10-21 SELL -1,008 87.300 87.480 87.462 USD -88,162 70.63 Loss of -16,971 on sale
2025-10-14 SELL -504 85.960 86.160 86.140 USD -43,415 70.21 Loss of -8,027 on sale
2025-10-02 SELL -2,047 86.280 88.660 88.422 USD -181,000 69.96 Loss of -37,793 on sale
2025-09-25 SELL -504 81.660 84.450 84.171 USD -42,422 69.59 Loss of -7,347 on sale
2025-09-09 SELL -1,082 85.600 87.350 87.175 USD -94,323 69.16 Loss of -19,494 on sale
2025-07-28 SELL -618 70.160 70.930 70.853 USD -43,787 68.26 Loss of -1,604 on sale
2025-07-15 SELL -2,296 68.250 70.150 69.960 USD -160,628 68.24 Loss of -3,954 on sale
2025-07-11 SELL -1,148 68.590 69.970 69.832 USD -80,167 68.23 Loss of -1,844 on sale
2025-07-02 BUY 573 68.170 69.100 69.007 USD 39,541 68.22
2025-06-30 SELL -1,728 68.100 68.820 68.748 USD -118,797 68.22 Loss of -918 on sale
2025-06-27 SELL -1,869 68.370 71.120 70.845 USD -132,409 68.22 Loss of -4,914 on sale
2025-06-26 BUY 575 70.810 71.500 71.431 USD 41,073 68.20
2025-06-25 SELL -576 67.550 69.140 68.981 USD -39,733 68.20 Loss of -448 on sale
2025-06-23 SELL -1,740 67.260 68.780 68.628 USD -119,413 68.20 Loss of -737 on sale
2025-06-20 SELL -580 68.460 69.190 69.117 USD -40,088 68.20 Loss of -530 on sale
2025-06-16 SELL -5,860 71.220 71.290 71.283 USD -417,718 68.18 Loss of -18,198 on sale
2025-06-13 SELL -577 67.750 68.960 68.839 USD -39,720 68.18 Loss of -380 on sale
2025-06-12 SELL -1,152 69.220 69.540 69.508 USD -80,073 68.17 Loss of -1,538 on sale
2025-06-11 SELL -2,880 68.850 70.360 70.209 USD -202,202 68.17 Loss of -5,876 on sale
2025-06-09 SELL -576 69.890 69.960 69.953 USD -40,293 68.14 Loss of -1,042 on sale
2025-05-30 SELL -573 65.060 65.770 65.699 USD -37,646 68.20 Profit of 1,434 on sale
2025-05-28 SELL -571 64.930 65.610 65.542 USD -37,424 68.24 Profit of 1,541 on sale
2025-05-21 SELL -571 64.780 65.460 65.392 USD -37,339 68.38 Profit of 1,706 on sale
2025-05-14 SELL -7,566 61.160 62.500 62.366 USD -471,861 68.58 Profit of 47,030 on sale
2025-05-09 BUY 2,951 58.980 60.480 60.330 USD 178,034 68.79
2025-05-07 SELL -2,276 59.550 60.070 60.018 USD -136,601 68.94 Profit of 20,300 on sale
2025-05-01 BUY 569 62.030 62.640 62.579 USD 35,607 69.19
2025-04-29 SELL -6,237 60.430 60.720 60.691 USD -378,530 69.32 Profit of 53,832 on sale
2025-04-28 SELL -571 59.520 59.600 59.592 USD -34,027 69.41 Profit of 5,605 on sale
2025-04-25 BUY 571 59.160 59.210 59.205 USD 33,806 69.50
2025-04-23 BUY 7,834 58.000 59.010 58.909 USD 461,493 69.70
2025-04-22 BUY 5,013 57.380 58.040 57.974 USD 290,624 69.81
2025-04-15 SELL -1,668 58.460 59.950 59.801 USD -99,748 70.25 Profit of 17,427 on sale
2025-04-14 BUY 2,918 59.220 59.300 59.292 USD 173,014 70.35
2025-04-11 BUY 2,813 56.870 57.070 57.050 USD 160,482 70.48
2025-04-09 SELL -1,659 58.860 59.370 59.319 USD -98,410 70.75 Profit of 18,960 on sale
2025-04-08 SELL -2,216 56.970 61.470 61.020 USD -135,220 70.88 Profit of 21,859 on sale
2025-04-07 SELL -554 60.290 61.060 60.983 USD -33,785 70.99 Profit of 5,544 on sale
2025-04-04 BUY 556 60.580 63.570 63.271 USD 35,179 71.10
2025-04-01 BUY 2,220 60.910 62.000 61.891 USD 137,398 71.29
2025-03-27 SELL -1,114 60.680 61.640 61.544 USD -68,560 71.63 Profit of 11,237 on sale
2025-03-21 SELL -557 61.920 62.330 62.289 USD -34,695 72.06 Profit of 5,442 on sale
2025-03-14 BUY 1,674 67.860 68.120 68.094 USD 113,989 72.64
2025-03-13 BUY 558 67.710 68.970 68.844 USD 38,415 72.70
2025-03-12 BUY 1,116 67.730 68.230 68.180 USD 76,089 72.76
2025-03-11 BUY 1,116 68.070 71.650 71.292 USD 79,562 72.82
2025-03-10 SELL -557 71.130 71.890 71.814 USD -40,000 72.84 Profit of 570 on sale
2025-03-07 BUY 9,418 70.790 72.810 72.608 USD 683,822 72.86
2025-03-05 BUY 2,780 69.810 69.970 69.954 USD 194,472 72.90
2025-03-04 BUY 1,112 69.680 70.000 69.968 USD 77,804 72.94
2025-03-03 BUY 2,224 70.260 73.450 73.131 USD 162,643 72.98
2025-02-27 BUY 556 73.180 74.600 74.458 USD 41,399 72.97
2025-02-26 BUY 4,432 74.300 75.310 75.209 USD 333,326 72.95
2025-02-25 BUY 1,108 74.400 76.240 76.056 USD 84,270 72.93
2025-02-20 BUY 1,662 71.380 71.520 71.506 USD 118,843 72.95
2025-02-05 BUY 553 75.260 75.740 75.692 USD 41,858 73.32
2025-02-04 BUY 553 74.120 74.920 74.840 USD 41,387 73.31
2025-01-31 SELL -551 74.160 75.180 75.078 USD -41,368 73.29 Loss of -986 on sale
2025-01-30 BUY 551 73.770 74.560 74.481 USD 41,039 73.28
2025-01-29 SELL -551 73.720 74.110 74.071 USD -40,813 73.27 Loss of -441 on sale
2025-01-28 BUY 1,102 73.150 73.990 73.906 USD 81,444 73.27
2025-01-27 SELL -551 72.640 73.430 73.351 USD -40,416 73.29 Loss of -36 on sale
2024-12-10 SELL -558 72.480 73.100 73.038 USD -40,755 73.33 Profit of 164 on sale
2024-12-03 SELL -1,118 72.030 72.960 72.867 USD -81,465 73.27 Profit of 445 on sale
2024-11-29 SELL -557 74.590 76.080 75.931 USD -42,294 73.23 Loss of -1,502 on sale
2024-11-25 SELL -23,732 73.520 73.870 73.835 USD -1,752,252 73.02 Loss of -19,290 on sale
2024-11-22 SELL -1,941 71.720 72.000 71.972 USD -139,698 73.06 Profit of 2,109 on sale
2024-11-05 SELL -5,168 77.280 77.370 77.361 USD -399,802 69.60 Loss of -40,128 on sale
2024-11-05 SELL -5,168 77.280 77.370 77.361 USD -399,802 69.60 Loss of -40,128 on sale
2024-10-29 BUY 645 73.600 74.070 74.023 USD 47,745 65.34
2024-10-29 BUY 645 73.600 74.070 74.023 USD 47,745 65.34
2024-10-24 BUY 645 65.240 65.910 65.843 USD 42,469 65.34
2024-10-24 BUY 645 65.240 65.910 65.843 USD 42,469 65.34
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-04	SELL	-1,064	103.860	100.020	100.404	USD -106,830	71.62 Loss of -30,629 on sale
2025-10-31	BUY	504	95.100	92.058	92.362	USD 46,550	71.37
2025-10-28	SELL	-1,008	91.650	93.980	93.747	USD -94,497	71.08 Loss of -22,844 on sale
2025-10-21	SELL	-1,008	87.300	87.480	87.462	USD -88,162	70.63 Loss of -16,971 on sale
2025-10-14	SELL	-504	85.960	86.160	86.140	USD -43,415	70.21 Loss of -8,027 on sale
2025-10-02	SELL	-2,047	86.280	88.660	88.422	USD -181,000	69.96 Loss of -37,793 on sale
2025-09-25	SELL	-504	81.660	84.450	84.171	USD -42,422	69.59 Loss of -7,347 on sale
2025-09-09	SELL	-1,082	85.600	87.350	87.175	USD -94,323	69.16 Loss of -19,494 on sale
2025-07-28	SELL	-618	70.160	70.930	70.853	USD -43,787	68.26 Loss of -1,604 on sale
2025-07-15	SELL	-2,296	68.250	70.150	69.960	USD -160,628	68.24 Loss of -3,954 on sale
2025-07-11	SELL	-1,148	68.590	69.970	69.832	USD -80,167	68.23 Loss of -1,844 on sale
2025-07-02	BUY	573	68.170	69.100	69.007	USD 39,541	68.22
2025-06-30	SELL	-1,728	68.100	68.820	68.748	USD -118,797	68.22 Loss of -918 on sale
2025-06-27	SELL	-1,869	68.370	71.120	70.845	USD -132,409	68.22 Loss of -4,914 on sale
2025-06-26	BUY	575	70.810	71.500	71.431	USD 41,073	68.20
2025-06-25	SELL	-576	67.550	69.140	68.981	USD -39,733	68.20 Loss of -448 on sale
2025-06-23	SELL	-1,740	67.260	68.780	68.628	USD -119,413	68.20 Loss of -737 on sale
2025-06-20	SELL	-580	68.460	69.190	69.117	USD -40,088	68.20 Loss of -530 on sale
2025-06-16	SELL	-5,860	71.220	71.290	71.283	USD -417,718	68.18 Loss of -18,198 on sale
2025-06-13	SELL	-577	67.750	68.960	68.839	USD -39,720	68.18 Loss of -380 on sale
2025-06-12	SELL	-1,152	69.220	69.540	69.508	USD -80,073	68.17 Loss of -1,538 on sale
2025-06-11	SELL	-2,880	68.850	70.360	70.209	USD -202,202	68.17 Loss of -5,876 on sale
2025-06-09	SELL	-576	69.890	69.960	69.953	USD -40,293	68.14 Loss of -1,042 on sale
2025-05-30	SELL	-573	65.060	65.770	65.699	USD -37,646	68.20 Profit of 1,434 on sale
2025-05-28	SELL	-571	64.930	65.610	65.542	USD -37,424	68.24 Profit of 1,541 on sale
2025-05-21	SELL	-571	64.780	65.460	65.392	USD -37,339	68.38 Profit of 1,706 on sale
2025-05-14	SELL	-7,566	61.160	62.500	62.366	USD -471,861	68.58 Profit of 47,030 on sale
2025-05-09	BUY	2,951	58.980	60.480	60.330	USD 178,034	68.79
2025-05-07	SELL	-2,276	59.550	60.070	60.018	USD -136,601	68.94 Profit of 20,300 on sale
2025-05-01	BUY	569	62.030	62.640	62.579	USD 35,607	69.19
2025-04-29	SELL	-6,237	60.430	60.720	60.691	USD -378,530	69.32 Profit of 53,832 on sale
2025-04-28	SELL	-571	59.520	59.600	59.592	USD -34,027	69.41 Profit of 5,605 on sale
2025-04-25	BUY	571	59.160	59.210	59.205	USD 33,806	69.50
2025-04-23	BUY	7,834	58.000	59.010	58.909	USD 461,493	69.70
2025-04-22	BUY	5,013	57.380	58.040	57.974	USD 290,624	69.81
2025-04-15	SELL	-1,668	58.460	59.950	59.801	USD -99,748	70.25 Profit of 17,427 on sale
2025-04-14	BUY	2,918	59.220	59.300	59.292	USD 173,014	70.35
2025-04-11	BUY	2,813	56.870	57.070	57.050	USD 160,482	70.48
2025-04-09	SELL	-1,659	58.860	59.370	59.319	USD -98,410	70.75 Profit of 18,960 on sale
2025-04-08	SELL	-2,216	56.970	61.470	61.020	USD -135,220	70.88 Profit of 21,859 on sale
2025-04-07	SELL	-554	60.290	61.060	60.983	USD -33,785	70.99 Profit of 5,544 on sale
2025-04-04	BUY	556	60.580	63.570	63.271	USD 35,179	71.10
2025-04-01	BUY	2,220	60.910	62.000	61.891	USD 137,398	71.29
2025-03-27	SELL	-1,114	60.680	61.640	61.544	USD -68,560	71.63 Profit of 11,237 on sale
2025-03-21	SELL	-557	61.920	62.330	62.289	USD -34,695	72.06 Profit of 5,442 on sale
2025-03-14	BUY	1,674	67.860	68.120	68.094	USD 113,989	72.64
2025-03-13	BUY	558	67.710	68.970	68.844	USD 38,415	72.70
2025-03-12	BUY	1,116	67.730	68.230	68.180	USD 76,089	72.76
2025-03-11	BUY	1,116	68.070	71.650	71.292	USD 79,562	72.82
2025-03-10	SELL	-557	71.130	71.890	71.814	USD -40,000	72.84 Profit of 570 on sale
2025-03-07	BUY	9,418	70.790	72.810	72.608	USD 683,822	72.86
2025-03-05	BUY	2,780	69.810	69.970	69.954	USD 194,472	72.90
2025-03-04	BUY	1,112	69.680	70.000	69.968	USD 77,804	72.94
2025-03-03	BUY	2,224	70.260	73.450	73.131	USD 162,643	72.98
2025-02-27	BUY	556	73.180	74.600	74.458	USD 41,399	72.97
2025-02-26	BUY	4,432	74.300	75.310	75.209	USD 333,326	72.95
2025-02-25	BUY	1,108	74.400	76.240	76.056	USD 84,270	72.93
2025-02-20	BUY	1,662	71.380	71.520	71.506	USD 118,843	72.95
2025-02-05	BUY	553	75.260	75.740	75.692	USD 41,858	73.32
2025-02-04	BUY	553	74.120	74.920	74.840	USD 41,387	73.31
2025-01-31	SELL	-551	74.160	75.180	75.078	USD -41,368	73.29 Loss of -986 on sale
2025-01-30	BUY	551	73.770	74.560	74.481	USD 41,039	73.28
2025-01-29	SELL	-551	73.720	74.110	74.071	USD -40,813	73.27 Loss of -441 on sale
2025-01-28	BUY	1,102	73.150	73.990	73.906	USD 81,444	73.27
2025-01-27	SELL	-551	72.640	73.430	73.351	USD -40,416	73.29 Loss of -36 on sale
2024-12-10	SELL	-558	72.480	73.100	73.038	USD -40,755	73.33 Profit of 164 on sale
2024-12-03	SELL	-1,118	72.030	72.960	72.867	USD -81,465	73.27 Profit of 445 on sale
2024-11-29	SELL	-557	74.590	76.080	75.931	USD -42,294	73.23 Loss of -1,502 on sale
2024-11-25	SELL	-23,732	73.520	73.870	73.835	USD -1,752,252	73.02 Loss of -19,290 on sale
2024-11-22	SELL	-1,941	71.720	72.000	71.972	USD -139,698	73.06 Profit of 2,109 on sale
2024-11-05	SELL	-5,168	77.280	77.370	77.361	USD -399,802	69.60 Loss of -40,128 on sale
2024-11-05	SELL	-5,168	77.280	77.370	77.361	USD -399,802	69.60 Loss of -40,128 on sale
2024-10-29	BUY	645	73.600	74.070	74.023	USD 47,745	65.34
2024-10-29	BUY	645	73.600	74.070	74.023	USD 47,745	65.34
2024-10-24	BUY	645	65.240	65.910	65.843	USD 42,469	65.34
2024-10-24	BUY	645	65.240	65.910	65.843	USD 42,469	65.34

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	321,923	395	451,110	71.4%
2025-09-18	244,947	1,423	469,747	52.1%
2025-09-17	277,858	779	546,953	50.8%
2025-09-16	359,781	946	576,379	62.4%
2025-09-15	347,453	4	582,228	59.7%
2025-09-12	353,040	0	631,534	55.9%
2025-09-11	448,733	3,894	739,701	60.7%
2025-09-10	490,727	248	671,932	73.0%
2025-09-09	515,395	1,822	682,791	75.5%
2025-09-08	308,184	119	479,828	64.2%
2025-09-05	256,719	2,505	512,049	50.1%
2025-09-04	422,624	1,507	834,717	50.6%
2025-09-03	381,679	7,777	624,922	61.1%
2025-09-02	547,120	15,396	816,267	67.0%
2025-08-29	148,294	262	304,427	48.7%
2025-08-28	164,008	0	347,480	47.2%
2025-08-27	248,926	453	513,401	48.5%
2025-08-26	365,130	6	709,320	51.5%
2025-08-25	478,130	1,306	642,319	74.4%
2025-08-22	344,352	2,023	596,301	57.7%
2025-08-21	198,729	4,881	335,301	59.3%
2025-08-20	351,699	3,977	555,345	63.3%
2025-08-19	343,110	3,146	574,328	59.7%
2025-08-18	366,124	4,996	653,103	56.1%
2025-08-15	480,885	8,035	625,797	76.8%
2025-08-14	593,554	36,654	806,068	73.6%
2025-08-13	845,181	98,160	1,257,503	67.2%
2025-08-12	462,896	42,208	678,689	68.2%
2025-08-11	385,211	696	595,892	64.6%
2025-08-08	248,925	738	426,187	58.4%
2025-08-07	268,864	929	420,486	63.9%
2025-08-06	554,642	891	731,484	75.8%
2025-08-05	361,687	2,092	623,879	58.0%
2025-08-04	338,005	1,464	519,150	65.1%
2025-08-01	414,814	828	572,879	72.4%
2025-07-31	570,845	6,148	777,417	73.4%
2025-07-30	471,303	14,166	881,194	53.5%
2025-07-29	966,640	10,581	1,593,701	60.7%
2025-07-28	382,236	62	625,510	61.1%
2025-07-25	216,967	49	422,990	51.3%
2025-07-24	348,276	23	528,517	65.9%
2025-07-23	297,903	583	487,297	61.1%
2025-07-22	267,987	172	446,489	60.0%
2025-07-21	223,626	380	406,729	55.0%
2025-07-18	241,218	108	471,589	51.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.